Health Care/Hospital
WuXi Biologics Receives AAA MSCI ESG Rating
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has received an AAA rating from Morgan Stanley Capital International (MSCI) ESG Ratings, the highest rating for compan...
2023-11-08 08:30
1556
Rootique DUO launches on Indiegogo, revolutionizing hair loss treatment with a 15s mess-free process
HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Rootique, a startup that leverages technology to optimize the performance of hair loss solutions, announced today the launch of its pioneering product Rootique DUO, designed to simplify the application of topical hair loss treatments to boost the chance of ...
2023-11-08 00:00
1433
MAJOR FITNESS opens pre-orders on its less space, more exercises foldable power rack, the Lightning F35
ATLANTA, Ga., Nov. 7, 2023 /PRNewswire/ -- Optimizing gym equipment so people
can train at home on a budget, even ifthey live in an apartment with limited
space, is in reach more than ever now with the launch of the newall-in-one
Lightning F35 from MAJOR FITNESS.
2023-11-07 22:00
1715
Nuevocor presents pre-clinical data at ESGCT and AHA meetings
SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnologycompany focused on developing cardiac genetic medicines through a unique platform to understand the mechanobiological causes of disease, announced today a pair of presentations at two major meetings, the European ...
2023-11-07 22:00
1758
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
SYDNEY, Nov. 7, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that 50 patients have no...
2023-11-07 21:58
1378
Kexing Biopharm Attended CPHI Worldwide 2023
SHENZHEN, China, Nov. 7, 2023 /PRNewswire/ -- Recently, CPHI Worldwide 2023 was successfully held inBarcelona, Spain. Kexing Biopharm exhibited more than ten kinds of high-quality medical products in the fields of tumor, autoimmune, anti-virus, etc., including Infliximab, Adalimumab, Bevacizumab,...
2023-11-07 20:09
1542
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC)
HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind, multicenter, phase III clinical study evaluating PD-1/CTLA-4 bispecific antibody, cadonilimab (开坦尼®) in combination with capecitabine plus...
2023-11-07 20:00
1945
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science
* Creating world-class innovation by redefining how international standards are established with eco-friendly bio materials and a system. * Patent registration for one-stop system from procurement of raw materials and golden time orders from all over the world to search for optimal routes for ...
2023-11-07 15:47
1840
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the first patient has been dosed in the Phase I Clinical trial of BRY812, a third-generation antibody-drug conjugate (ADC) targeting LIV-1 for the treatment of advanced malign...
2023-11-07 14:14
1413
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting
SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that two major clinical updates of its CSF-1R inhibitor pimicotinib（ABSK021）were presented at the 2023 Connective Tissue Oncology Society Annual Meeting, which is held inIreland from...
2023-11-07 12:31
1516
AIRS Medical inks partnership agreement with FONAR Corporation, leveraging the experience of the pioneering company in MRI... Success cases to be presented at RSNA 2023
SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- AIRS Medical, the leading AI-powered healthcare solution provider, recently announced a strategic partnership with FONAR Corporation (NASDAQ:FONR), the pioneer company in the MRI industry, to accelerate and develop business inNorth America. AIRS M...
2023-11-07 00:00
1828
Lerna Bio unveils its first-in-class solution to combat liver failure
SINGAPORE, CAMBRIDGE, Mass. and SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Lerna Biopharma Pte. Ltd (Lerna Bio) proudly announces the unveiling of its pioneering liver regeneration drug candidate, LR1, at The Liver Meeting inBoston organized by American Association for the Study of Liver Diseases (AA...
2023-11-06 22:00
1495
I-Mab Announces Participation at Jefferies and Piper Conferences in November
ROCKVILLE, Md. and SHANGHAI, China, Nov. 6, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies...
2023-11-06 21:00
1447
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023
* Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer ...
2023-11-06 21:00
1473
First in the U.S! Palliative Care VR Educational Material by Jolly Good and Emergency Medicine Specialists
Jolly Good to hold VR Seminar at GSA 2023, Gerontological Society of America! TOKYO, Nov. 6, 2023 /PRNewswire/ -- Jolly Good US Inc. (Brookline, Massachusetts, USA CEO: Kensuke Joji), a developer of medical VR, is pleased to announce that it has developed the first "Palliative Care Communication ...
2023-11-06 21:00
1484
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
Bispecific Antibody Candidate PM8002 demonstrated encouraging data at this year's ASCO Annual Meeting (abstract #2536 & #e13091) and ESMO Congress (abstract #1992P) BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China ZHUHAI, China, Nov. 6...
2023-11-06 20:00
2251
Dr.FORHAIR Announces U.S. In-Store Launch of Best Selling Hair Loss Shampoo
Global Scalp Care Brand to Launch Folligen Original Shampoo in 50 U.S. Costco Branches After Being Sold Online LOS ANGELES, Sept. 25, 2023 /PRNewswire/ -- Dr.FORHAIR, a global scalp care brand, has announced the first offline launch of its best selling Folligen Original Shampoo across 50 Costco ...
2023-11-06 16:48
1061
David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep
LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer,
distributor, and retailer of premium bedding products worldwide, has today
announced the signing ofDavid Beckham as its newest brand ambassador.
2023-11-06 11:00
3691
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug...
2023-11-06 09:11
1494
PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association
SEOUL, South Korea, Nov. 5, 2023 /PRNewswire/ -- With much anticipation surrounding its impending release, PillWork officially announces its launch scheduled for the end of 2023. An integral part of this excitement is the company's crucial alliance with the esteemed Precision Nutrition Associatio...
2023-11-06 09:00
1365
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6494
